CLINICAL_TRIALS
research
· 2020-01-07
Clinical Trial Update: CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes [Phase 3]
Summary
Clinical trial update for CAROLINA comparing linagliptin vs glimepiride in type 2 diabetes; study completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2020-01-07